PharmaShots | Incisive News in 3 Shots

Subscribe Now

Asieris Pharmacetuicals

Asieris Receives the TGA’s Approval to Initiate P-I Trial for APL-2301 to Treat Acinetobacter baumannii Infection

Asieris Receives the TGA’s Approval to Initiate P-I Trial for APL-2301 to Treat Acinetobacter baumannii Infection

December 26, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us